1Girling DJ. Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trial.Medical Research Council Lung Cancer Working Party. Lancet,1996,348 (9027):563-566.
2Okamoto H, Watanabe K, Nishiwaki Y,et al. Phase Ⅱ study of area under the plasma-concentration-versus-time curvebased carboplatin plus standard-dose intravenous etoposide in elderly patients with small-cell lung cancer. J Clin Oncol, 1999,17(11): 3540-35
3Zochbauer-Muller S, Pirker R, Huber H,et al. Treatment of small cell lung cancer patients. Ann Oncol, 1999,10 (Suppl 6) :83-91.
4Byrne A, Carney DN. Small cell lung cancer in the elderly. Semin Oncol, 1994,21(3Suppl 6): 43-48.
5Michel G, Leyvraz S, Bauer J, et al.Weekly carboplatin and VM-26 for elderly patients with small-cell lung cancer. Ann Oncol,1994,5(4): 369-370.
6Gridelli C, De Vivo R, Monfardini S.Management of small-cell lung cancer in the elderly. Crit Rev Oncol Hematol,2002,41(1): 79-88.
7Extermann M. Measuring comorbidity in older cancer patients. Eur J Cancer,2000,36(4): 453-471.
8Satoh H, Ohtsuka M, Sekizawa K. Chemotherapy for elderly SCLC patients.Lung Cancer,2003,40(1): 107.
9Gatzmeier U, Nenhauss R, Heckmayr M,et al. Single agent oral etoposide in advanced NSCLC (chronic daily) and in elderly patients with SCLC. Lung Cancer,1991,7(Suppl 1) : 102.
10Tummarello D, Isidori P, Pasini F, et al.Teniposide as single drug therapy for elderly patients affected by small cell lung cancer. EurJ Cancer,1992,28A(6-7) : 1081-1084.
